Surgery Partners (NASDAQ:SGRY) Stock Rating Reaffirmed as “Outperform” by Royal Bank Of Canada

Surgery Partners (NASDAQ:SGRY)‘s stock had its “outperform” rating reiterated by stock analysts at Royal Bank Of Canada in a research note issued to investors on Wednesday, Benzinga reports. They presently have a $19.00 target price on the stock. Royal Bank Of Canada’s price target suggests a potential upside of 36.89% from the company’s current price.

SGRY has been the subject of several other reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Surgery Partners in a research note on Friday, August 21st. Benchmark reaffirmed a “buy” rating on shares of Surgery Partners in a research report on Tuesday, August 11th. Zacks Research lowered Surgery Partners from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 10th. Raymond James Financial set a $18.00 target price on Surgery Partners in a research note on Tuesday, August 11th. Finally, TD Cowen reissued a “buy” rating and issued a $19.00 price target on shares of Surgery Partners in a research report on Friday, September 18th. Seven investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Surgery Partners currently has a consensus rating of “Moderate Buy” and an average target price of $19.00.

Surgery Partners Stock Up 0.1%

SGRY opened at $13.88 on Wednesday. The stock’s 50 day moving average price is $14.58 and its 200 day moving average price is $14.30. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.95 and a quick ratio of 1.78. The stock has a market cap of $1.82 billion, a P/E ratio of -19.82, a P/E/G ratio of 4.46 and a beta of 1.92. Surgery Partners has a 12 month low of $11.41 and a 12 month high of $23.44.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings results on Monday, August 10th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.04. Surgery Partners had a positive return on equity of 0.88% and a negative net margin of 2.63%.The company had revenue of $848.90 million during the quarter, compared to analysts’ expectations of $830.03 million. During the same quarter in the prior year, the business posted $0.17 earnings per share. The company’s revenue for the quarter was up 2.7% compared to the same quarter last year. As a group, research analysts predict that Surgery Partners will post 0.25 earnings per share for the current year.

Insider Transactions at Surgery Partners

In other news, Director Teresa DeLuca bought 10,000 shares of the stock in a transaction that occurred on Tuesday, August 18th. The shares were acquired at an average cost of $14.35 per share, for a total transaction of $143,500.00. Following the purchase, the director owned 66,843 shares of the company’s stock, valued at $959,197.05. This represents a 17.59% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 2.00% of the stock is owned by insiders.

Institutional Trading of Surgery Partners

A number of institutional investors and hedge funds have recently modified their holdings of the company. ProShare Advisors LLC raised its holdings in shares of Surgery Partners by 6.9% in the 4th quarter. ProShare Advisors LLC now owns 14,135 shares of the company’s stock worth $218,000 after buying an additional 909 shares in the last quarter. Swiss National Bank increased its holdings in Surgery Partners by 1.1% during the 1st quarter. Swiss National Bank now owns 153,500 shares of the company’s stock valued at $1,830,000 after purchasing an additional 1,700 shares in the last quarter. PNC Financial Services Group Inc. boosted its stake in Surgery Partners by 239.6% in the first quarter. PNC Financial Services Group Inc. now owns 2,907 shares of the company’s stock worth $35,000 after purchasing an additional 2,051 shares in the last quarter. Public Employees Retirement System of Ohio acquired a new stake in shares of Surgery Partners in the second quarter valued at $38,000. Finally, Fifth Third Bancorp raised its holdings in shares of Surgery Partners by 5,324.0% in the first quarter. Fifth Third Bancorp now owns 4,068 shares of the company’s stock valued at $48,000 after buying an additional 3,993 shares during the last quarter.

About Surgery Partners

Surgery Partners, Inc (NASDAQ: SGRY) is a healthcare services company that owns and operates a network of ambulatory surgery centers and surgical hospitals in the United States. The company works with physicians and health systems to provide outpatient and same-day surgical care in settings outside traditional hospital facilities.

Its services cover a range of specialties, including orthopedics, pain management, gastroenterology, ophthalmology, gynecology, urology and other procedural areas.